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Brief Report

Health care worker follow-up compliance after occupational
bloodborne pathogens exposure: A brief report
CPT Juan C. Díaz MC, USA *, LCDR Lucas A. Johnson MC, USN
Uniformed Services University of the Health Sciences, Bethesda, MD
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A retrospective cohort study was conducted examining health care worker (HCW) compliance with Centers
for Disease Control and Prevention recommendations following occupational bloodborne pathogen (BBP)
exposure. HCWs with a BBP exposure from a known HIV- or hepatitis C virus-seropositive individual were
less likely to complete recommended follow-up compared with HCWs with seronegative source patient
exposures (adjusted odds ratio, 0.02 and 0.09, respectively). Continued targeted education and extra vigilance in performing postexposure surveillance are warranted in this higher-risk population.
Published by Elsevier Inc. on behalf of Association for Professionals in Infection Control and
Epidemiology, Inc.

BACKGROUND

METHODS

Exposure to bloodborne pathogens (BBPs) is a well-described occupational hazard affecting an estimated 385,000 health care workers
(HCWs) annually.1 Sharps injuries sustained by HCWs while providing patient care can potentially transmit more than 20 pathogens,
most commonly hepatitis B virus (HBV), hepatitis C virus (HCV), and
HIV.1 An estimated 8% of HCV, 1% of HBV, and 0.5% of HIV infections in HCWs are directly attributable to occupational sharps
injuries2; risk of seroconversion after percutaneous exposure to seropositive source patients is estimated at 6%-30% for HBV, 0.5%-2%
for HCV, and 0.3% for HIV.3,4
The Centers for Disease Control and Prevention (CDC) recommends health care institutions implement postexposure protocols
for injured HCWs, including assessment of source patients for evidence of HIV, HCV, and HBV infection as well as periodic followup testing and management of the injured HCW.3-5 Although previous
studies demonstrate HCW compliance with performing CDCrecommended follow-up ranges between 33% and 87%, none have
systematically evaluated factors inﬂuencing HCW completion of
follow-up.6,7

A retrospective cohort study was designed using de-identiﬁed
data routinely collected by the occupational medicine department of a large military treatment facility to evaluate clinical and
demographic factors inﬂuencing HCW completion of CDCrecommended follow-up. Subjects were eligible for inclusion if they
reported an occupational BBP exposure to the hospital’s occupational medicine clinic or emergency room from August 1, 2011October 31, 2014. Hospital resident physicians and fellows sustaining
offsite occupational exposures while performing a rotation at another
facility were also eligible for inclusion because hospital policy mandated local administrative tracking and management of such
exposures. The surveillance period was from August 1, 2011March 31, 2015, to allow subjects to complete a minimum of 6
months of follow-up after exposure. Primary outcome measure
was completion of CDC-recommended management and followup testing deﬁned as completion of all required postexposure
laboratory studies at least once a minimum of 6 months after
exposure.
Analysis of demographic and clinical covariate inﬂuence upon
outcome was restricted only to those HCWs who had the opportunity to complete at least 6 months of follow-up after exposure.
Two separate multivariate models were generated (1 evaluating inﬂuence of HIV source patient seropositivity and 1 for HCV) because
inclusion of both HIV and HCV covariates into a single model resulted in zero cell counts and prohibited performance of logistic
regression. This project was reviewed and approved by the Uniformed Services University of the Health Sciences’ Oﬃce of Research
(T0873293) and Walter Reed National Military Medical Center Institutional Review Board (408721-1).
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RESULTS
A total of 582 occupational BBP exposures were reported during
the exposure period (Table 1). The majority of exposures involved
source patients with no serologic evidence of HIV (73.6%; n = 428),
HBV (75.3%; n = 438), or HCV (73.2%; n = 426).

Table 1
Characteristics of health care workers with reported bloodborne pathogens exposure, by completion of follow-up
Completion of
follow-up*

n (%)
Risk factor
Employment status
Active duty
Civilian
Contractor
General schedule
Unknown
Institution role
Medical student
Midlevel provider
Nurse
Physician
Medical technician
Other
Department
Dental
Fire/police
Housekeeping
Medicine
Offsite
SPD
Surgery
Unknown
Injury location
Arm
Eye/face/mouth
Hand/ﬁnger
Leg
Other
Instrument type
Blade
Hollow needle
Instrument
Needle, unknown type
Solid needle
Splash
Other
Source HIV rapid test
Negative
Positive
Unknown
Source hepatitis C status
Negative
Positive
Unknown
Source hepatitis B status
Negative
Positive
Unknown
Infectious diseases
department referral
No
Yes
Placed on PEP
No
Yes

N = 582

Yes (%)

No (%)

414 (87.5)

59 (12.5)

Total 473

χ2 P value
.08

436 (74.9)
45 (7.7)
66 (11.3)
34 (5.8)
1 (.2)

310 (87.3)
40 (93.0)
45 (86.5)
19 (86.4)
0 (0.0)

45 (12.7)
3 (7.0)
7 (13.5)
3 (13.6)
1 (100.0)

23 (4.0)
19 (3.3)
124 (21.3)
161 (27.7)
201 (34.5)
54 (9.3)

17 (94.4)
14 (87.5)
91 (91.9)
127 (90.1)
129 (83.8)
36 (80.0)

1 (5.6)
2 (12.5)
8 (8.1)
14 (9.9)
25 (16.2)
9 (20.0)

34 (5.8)
3 (.5)
21 (3.6)
239 (41.1)
17 (2.9)
25 (4.3)
239 (41.1)
4 (.7)

24 (88.9)
1 (33.3)
14 (82.4)
173 (87.4)
11 (73.3)
15 (75.0)
172 (91.0)
4 (100.0)

3 (11.1)
2 (66.7)
3 (17.6)
25 (12.6)
4 (26.7)
5 (25.0)
17 (9.0)
0 (0.0)

23 (4.0)
118 (20.3)
423 (72.7)
9 (1.5)
9 (1.5)

17 (89.5)
79 (81.4)
310 (90.4)
4 (66.7)
4 (50.0)

2 (10.5)
18 (18.6)
33 (9.6)
2 (33.3)
4 (50.0)

42 (7.2)
190 (32.6)
77 (13.2)
22 (3.8)
126 (21.6)
114 (19.6)
11 (1.9)

32 (94.1)
141 (91.0)
51 (85.0)
19 (90.5)
97 (94.2)
65 (73.0)
9 (81.8)

2 (5.9)
14 (9.0)
9 (15.0)
2 (9.5)
6 (5.8)
24 (27.0)
2 (18.2)

428 (73.6)
17 (2.9)
137 (23.5)

338 (96.8)
6 (37.5)
70 (64.8)

11 (3.2)
10 (62.5)
38 (35.2)

426 (73.2)
14 (2.4)
142 (24.4)

337 (97.4)
7 (50.0)
70 (61.9)

9 (2.6)
7 (50.0)
43 (38.1)

438 (75.3)
3 (.5)
141 (24.2)

341 (95.3)
3 (100.0)
70 (62.5)

17 (4.7)
0 (0.0)
42 (37.5)

.01

<.01

<.01

<.01

<.01

.43

<.01
392 (90.1)
22 (57.9)

43 (9.9)
16 (42.1)

17 (37.8)
28 (62.2)

7 (46.7)
15 (65.2)

8 (53.3)
8 (34.8)

Of the 473 subjects whose date of injury afforded a minimum
of 6 months of observation, 88% (n = 414) completed CDCrecommended follow-up. Institution role, department, injury
location, instrument type, source HIV status, source HCV status, and
infectious diseases department referral were signiﬁcantly associated with the outcome on χ2 analysis.
On univariate analysis, HCWs with exposure to a known HIVseropositive source were 98% less likely to complete follow-up (odds
ratio [OR], 0.02; 95% conﬁdence interval [CI], 0.01-0.07) when compared with subjects exposed to a HIV-negative source; these ﬁndings
persisted after multivariate adjustment (adjusted OR [aOR], 0.02;
95% CI, 0.004-0.13) (Table 2). Those exposed to source patients with
unknown HIV serostatus demonstrated similarly decreased likelihood of follow-up (aOR, 0.03; 95% CI, 0.01-0.08).
Source patient HCV serostatus similarly inﬂuenced likelihood of
follow-up completion. On crude analysis, subjects with exposure
to a known HCV-seropositive source patient were 97% less likely
to complete follow-up when compared with subjects exposed to a
known seronegative HCV source (OR, 0.03; 95% CI, 0.01-0.10); these
ﬁndings persisted after multivariate adjustment (aOR, 0.09; 95% CI,
0.02-0.45). Again, those exposed to source patients with unknown
HCV serostatus demonstrated decreased likelihood of follow-up (aOR,
0.02; 95% CI, 0.01-0.06).
DISCUSSION

.02

537 (92.3)
45 (7.7)

1739

.13

PEP, post exposure prophylaxis.
*Completion of follow-up restricted to subjects with at least 6 months of observation after exposure (August 1,2011-March 31, 2014).

HCWs with a BBP exposure involving HIV or HCV seropositive
or serostatus unknown patients were less likely to complete followup compared with HCWs exposed to seronegative source patients.
At least 2 possible explanations exist for these surprising ﬁndings.
First, the study design necessarily resulted in differential outcome
assessment bias because a seronegative source exposure resulted
in achieving outcome status with relative ease (essentially at time
of presentation) compared with an HCW with an HIV- or HCVseropositive source exposure requiring 6 months of follow-up to
achieve outcome status. A second possible explanation can be found
in the health belief model, a psychological model evaluating behavior using the 3 constructs of threat perception, beneﬁt perception,
and perceived disadvantage.8 Per hospital protocol, HCWs exposed
to known HIV or HCV patients received consultation with infectious diseases specialists who perform a review of source patient
infectivity, including a review of source patient viral suppressive
therapy and viral load (data unavailable to the hospital occupational medicine clinic). It is possible that follow-up compliance may
be affected by an HCWs low-perceived susceptibility following delivery of these data during specialist assessment; however, the deidentiﬁed data source utilized for this study prevented retrospective
record review to explore such a hypothesis.
Interpretation of this study is subject to several limitations. BBP
exposures are historically underreported. Despite an institutional
policy mandating self-reporting, undoubtedly some individuals chose
not to report a BBP exposure. Additionally, exposed HCWs with a
sophisticated understanding of BBP exposure risk may self-stratify,
resulting in an overly complaint cohort more motivated to complete therapy. Several demographic factors (eg, age, sex, race, and
assessment of personal protective equipment use) were not systematically recorded and were unavailable for analysis. Finally, the
study design resulted in differential observation time for exposed
HCWs based on source serostatus.
Postexposure programs are essential to sustaining a healthy workforce and preventing pathogen transmission. These study results
highlight need for further research to more completely assess factors
differentially inﬂuencing the personal motivations for complying with
recommended follow-up after BBP exposures, particularly for patients with higher-risk exposures.
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Table 2
Health care worker crude and adjusted odds ratios (ORs) and 95% conﬁdence intervals (CIs) for completion of follow-up after occupational bloodborne pathogen exposure:
HIV and hepatitis C virus (HCV) models
HIV model

Characteristics
Institution role
Medical student
Midlevel provider
Nurse
Physician
Tech/corpsman/medic
Other
Department
Surgery
Fire/police
Housekeeping
Medicine
Offsite
SPD
Dental
Injury location
Hand or ﬁnger
Arm
Eye/face/mouth
Other
Leg
Instrument type
Solid needle
Blade
Hollow needle
Instrument
Needle, unknown type
Other
Splash
Source rapid HIV test
Negative
Positive
Unknown
Referral to infectious diseases department
No
Yes

HCV model

Crude OR

Adjusted model*

OR (95% CI)

OR (95% CI)

Reference category
0.82 (0.10-6.62)
1.34 (0.26-6.86)
1.07 (0.22-5.11)
0.61 (0.13-2.79)
0.47 (0.09-2.42)

Crude odds ratio

Adjusted model*

P value

OR (95% CI)

OR (95% CI)

P value

Reference category
0.60 (0.03-10.79)
2.08 (0.18-24.62)
1.44 (0.13-16.49)
1.45 (0.14-14.98)
1.89 (0.12-29.82)

.73
.56
.77
.76
.65

Reference category
0.82 (0.10-6.62)
1.34 (0.26-6.86)
1.07 (0.22-5.11)
0.61 (0.13-2.79)
0.47 (0.09-2.42)

Reference category
1.21 (0.05-28.61)
2.40 (0.20-29.39)
1.28 (0.11-14.93)
1.65 (0.15-17.71)
3.14 (0.19-53.29)

.91
.49
.85
.68
.43

Reference category
0.05 (0.01-0.60)
0.49 (0.13-1.86)
0.72 (0.38-1.38)
0.29 (0.08-1.00)
0.31 (0.10-0.97)
0.84 (0.23-3.06)

Reference category
0.09 (0.01-2.37)
1.73 (0.19-16.19)
0.69 (0.25-1.90)
1.12 (0.19-6.83)
2.07 (0.42-10.24)
1.36 (0.17-10.76)

.15
.63
.48
.9
.37
.77

Reference category
0.05 (0.01-0.60)
0.49 (0.13-1.86)
0.72 (0.38-1.38)
0.29 (0.08-1.00)
0.31 (0.10-0.97)
0.84 (0.23-3.06)

Reference category
0.41 (0.003-61.39)
1.64 (0.17-15.82)
0.78 (0.29-2.13)
1.04 (0.16-6.77)
2.37 (0.47-12.05)
1.65 (0.22-12.40)

.73
.67
.63
.97
.3
.63

Reference category
0.93 (0.21-4.21)
0.48 (0.26-0.90)
0.11 (0.03-0.46)
0.22 (0.04-1.24)

Reference category
2.49 (0.20-30.51)
1.44 (0.29-7.15)
0.14 (0.01-1.56)
0.28 (0.02-3.84)

.48
.66
.11
.34

Reference category
0.93 (0.21-4.21)
0.48 (0.26-0.90)
0.11 (0.03-0.46)
0.22 (0.04-1.24)

Reference category
0.67 (0.10-4.50)
1.43 (0.26-7.89)
0.18 (0.02-2.06)
0.94 (0.07-12.97)

.68
.68
.17
.94

Reference category
0.99 (0.19-5.15)
0.62 (0.23-1.68)
0.35 (0.12-1.04)
0.59 (0.11-3.14)
0.28 (0.05-1.59)
0.17 (0.07-0.43)

Reference category
2.46 (0.37-16.15)
1.16 (0.30-4.52)
0.31 (0.07-1.41)
1.41 (0.19-10.37)
0.92 (0.10-8.42)
0.17 (0.03-1.11)

.35
.83
.13
.74
.94
.06

Reference category
0.99 (0.19-5.15)
0.62 (0.23-1.68)
0.35 (0.12-1.04)
0.59 (0.11-3.14)
0.28 (0.05-1.59)
0.17 (0.07-0.43)

Reference category
3.04 (0.41-22.67)
1.44 (0.37-5.63)
0.51 (0.11-2.31)
1.35 (0.19-9.32)
1.15 (0.13-9.84)
0.18 (0.03-1.20)

.28
.6
.38
.76
.9
.08

Reference category
0.02 (0.01-0.07)
0.07 (0.03-0.13)

Reference category
0.02 (0.004-0.13)
0.03 (0.01-0.08)

<.01
<.01

Reference category
0.03 (0.01-0.10)
0.05 (0.02-0.10)

Reference category
0.09 (0.02-0.45)
0.02 (0.01-0.06)

<.01
<.01

Reference category
0.15 (0.08-0.32)

Reference category
0.41 (0.12-1.39)

.15

Reference category
0.15 (0.08-0.32)

Reference category
0.12 (0.04-0.37)

<.01

SPD, sterile processing.
*Models include institution role, department, injury location, instrument type, source rapid HIV test, and infectious diseases referral.
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